MedTrace Logo

Normal Human Plasma Level of iNOS Study

NCT01605695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-11-26

No results posted yet for this study

Summary

The discovery that inducible nitric oxide synthase (iNOS) circulates in people who are developing the sepsis pathology has provided an opportunity to develop a first-in-class diagnostic test for the onset of sepsis. This study is designed to determine the normal human plasma level of circulating iNOS as the initial reference level against which hospitalized patients at risk for the development of sepsis can be compared to ascertain if the patient is at risk for becoming septic based upon an elevated level of plasma iNOS.

Conditions

  • Normal Human Plasma Level of iNOS

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • Research & Diagnostic Antibodies

    lead INDUSTRY

Principal Investigators

  • Robert J Webber, Ph.D. · Research & Diagnostic Antibodies

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-05-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01605695 on ClinicalTrials.gov